<DOC>
	<DOCNO>NCT00336245</DOCNO>
	<brief_summary>A randomized trial intrauterine contraceptive device ( IUD ) versus user 's choice hormonal contraception ( injectable progestin oral contraceptive pill ) among HIV-infected , recently post-partum woman Lusaka , Zambia .</brief_summary>
	<brief_title>A Randomized Trial IUD Versus Hormonal Contraception HIV-infected Women Zambia</brief_title>
	<detailed_description>In year 2000 , 37 , 000 new acceptor family plan Lusaka District Clinics . A variety method prescribe , include combine oral contraceptive pill , injectable progestin , intrauterine copper device , condom , others . The recent sentinel survey reproductive age woman estimate approximately 30 % reproductive age woman Lusaka HIV-infected . Since voluntary HIV counsel test yet universally available many district clinic , woman receive different type contraception regardless HIV status . There observational data publish recently suggest hormonal contraception may increase HIV viral load female genital tract potentially increase HIV transmission male partner . By contrast , barrier method historically unpopular stable couple use consistently many case despite intensive counseling . The IUCD represent one inexpensive effective method birth control available Lusaka . However , study adequately make policy recommendation regard use HIV infect woman . The purpose study evaluate safety acceptability IUCD versus hormonal method contraception HIV-infected uninfected woman Lusaka . Specifically , 1 ) compare contraceptive effectiveness IUCD standard practice user-chosen hormonal contraception , 2 ) compare rate pelvic infection IUD hormonal contraceptive user , 3 ) compare rate method discontinuation . Patients continue second trimester pregnancy , serologically confirm HIV infection , desire 24 month contraception , willingness randomly assign either IUCD hormonal contraception postpartum screen 32 week pregnancy receive either IUCD user choose hormonal contraception postpartum . Women see postpartum week 4-6 method randomization month 6 , 12 , 18 24 monitor pregnancy , continuation method , side effect problem . Women encourage return problem time . At least yearly , woman complete physical exam . CD4 HIV clinical status monitor regularly .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Copper</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>desire least 2 year continuous contraception two few sexual partner prior year advance HIV disease ( WHO Stage III IV ) history bleed disorder history PID within prior five year less 16 year age ( `` age majority '' Zambia ) .</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Contraception</keyword>
	<keyword>Women</keyword>
	<keyword>HIV/AIDS</keyword>
	<keyword>IUD</keyword>
	<keyword>IUCD</keyword>
</DOC>